Expanded Programme on Immunization

Expanded Programme on Immunization. Launched in 1974 by the World Health Organization, this global initiative was established to systematically provide childhood immunization against key infectious diseases worldwide. It represents a foundational effort in international public health, aiming to make life-saving vaccines universally accessible. The program has evolved into a cornerstone of primary health care, involving a vast network of global and national partners.

History and establishment

The program was formally proposed by the World Health Assembly in 1974, building upon the monumental success of the smallpox eradication campaign. Its creation was driven by the stark reality of low vaccination coverage in many developing nations, where diseases like measles and polio remained major causes of child mortality. Key architects within the World Health Organization, influenced by earlier work in epidemiology, sought to create a standardized framework for immunization delivery. The initiative gained rapid political support, aligning with the broader goals of the Alma Ata Declaration on primary health care in 1978.

Objectives and scope

The primary objective was to immunize all children against six target diseases: tuberculosis, diphtheria, pertussis, tetanus, polio, and measles. This scope was later expanded to include additional vaccine-preventable illnesses such as yellow fever and hepatitis B. A core aim was to strengthen national health system infrastructure, moving beyond campaign-based approaches to establish routine immunization services. The program also focused on developing robust surveillance systems for vaccine-preventable diseases and securing sustainable vaccine supply chains through partnerships with organizations like UNICEF.

Vaccines and schedule

The initial schedule centered on the administration of BCG vaccine at birth, followed by three doses of DPT vaccine and oral polio vaccine starting at six weeks of age, and a dose of measles vaccine at nine months. This regimen was designed by World Health Organization experts to balance immunogenicity and logistical feasibility in diverse settings. Over decades, the schedule has been progressively updated to incorporate new vaccines such as Hepatitis B vaccine, Haemophilus influenzae type b vaccine, pneumococcal conjugate vaccine, and rotavirus vaccine. National immunization schedules, such as those in India or Nigeria, are often adapted from these World Health Organization recommendations.

Implementation and strategies

Implementation relies on a decentralized model, with the World Health Organization and UNICEF providing technical guidance and support to national governments. A landmark strategy was the establishment of the Cold chain system to maintain vaccine potency during storage and transport, a critical innovation for reaching remote areas. Major initiatives like National Immunization Days, particularly for polio eradication, became hallmarks of the program's tactical approach. The formation of Gavi, the Vaccine Alliance in 2000 provided a major boost by improving vaccine affordability and financing for lower-income countries.

Impact and achievements

The program's impact is demonstrated by the dramatic global increase in DPT vaccine coverage from below 5% in 1974 to over 85% by the 2010s. It has been instrumental in reducing global child mortality, contributing significantly to the Millennium Development Goals. The initiative provided the foundational platform for the ongoing polio eradication effort, which has seen wild poliovirus eliminated in all but two countries, Afghanistan and Pakistan. Furthermore, the program's infrastructure proved vital for responding to other health crises, including the COVID-19 pandemic vaccination rollout.

Challenges and future directions

Persistent challenges include reaching underserved populations in conflict zones like the Democratic Republic of the Congo or remote regions of the Amazon rainforest, where health system access is limited. The rise of vaccine hesitancy, influenced by misinformation, poses a growing threat to coverage levels in communities from Europe to South Asia. Future directions involve integrating new vaccine technologies, such as those for malaria and human papillomavirus, and strengthening systems for adult immunization. The program continues to adapt under the umbrella of the Immunization Agenda 2030, aiming to leave no one behind. Category:World Health Organization programmes Category:Immunization